Raltegravir, Indinavir, Tipranavir, Dolutegravir, and Etravirine against main protease and RNA-dependent RNA polymerase of SARS-CoV-2: A molecular docking and drug repurposing approach

• Hoofdauteurs: Purushothaman Indu (Auteur), Marimuthu Ragavan Rameshkumar (Auteur), Narasingam Arunagirinathan (Auteur), Naif Abdullah Al-Dhabi (Auteur), Mariadhas Valan Arasu (Auteur), Savarimuthu Ignacimuthu (Auteur)
• Formaat: Boek
• Gepubliceerd in: Elsevier, 2020-12-01T00:00:00Z.
• Onderwerpen: article
• Online toegang: Connect to this object online.

Background: Outbreak of COVID-19 has been recognized as a global health concern since it causes high rates of morbidity and mortality. No specific antiviral drugs are available for the treatment of COVID-19 till date. Drug repurposing strategy helps to find out the drugs for COVID-19 treatment from...